Match Group Teams Up With White House To Promote COVID-19 Vaccines

Match Group announced today it has teamed up with the White House to promote COVID-19 vaccinations across its leading U.S. brands including Tinder, Match, OkCupid, Hinge, Plenty of Fish, BLK and Chispa. Campaigns will include information on where to find COVID-19 vaccine sites, vaccination badges for singles to display on their profiles, as well as free “Super Likes” and other boost-type features for U.S. users who say they are vaccinated.

The campaigns will launch in the coming weeks and run until July 4th.

“Human connection is so vital for healthy lives — it’s why I am so committed to this business,” said Shar Dubey, CEO of Match Group. “We are honored to work with the White House on increasing vaccinations across America, which will allow people to once again meet in person and engage in meaningful ways. This will make dating safer for everyone, everywhere.”

For many users across Match Group’s dating platforms, COVID-19 vaccinations are seen as a necessary step for singles to be able to date safely in person. Users this year have proactively posted about their vaccine status and say they view this as an important component of compatibility.

Below are examples of vaccine promotion campaigns launching across Match Group:

  • Tinder — Members will be able to add a variety of stickers to their profile including “I’m Vaccinated” or “Vaccines Save Lives,” with Tinder giving those who support the campaign a free “Super Like” to help them stand out among potential matches starting in early June. Tinder will also launch a “Vaccine Center” with a suite of resources to educate and connect members with their nearest vaccination site. Tinder was introduced on a college campus in 2012 and is the world’s most popular app for meeting new people.
  • Match — Members will be able to add a new “Vaccinated” badge to their profile to display their vaccine status, with those who participate in the campaign receiving a free “Boost” to help them stand out on the app. As the #1 dating app for singles looking for love, Match is ready to help singles get back to dating safely.
  • OkCupid — Daters will be able to add an “I’m Vaccinated” profile badge and be featured within OkCupid’s “Vaccinated” stack, its new matching system that lets users search by select categories on the app. Those who participate will also receive a free “Boost.” The campaign will begin May 24th. OkCupid is the dating app made famous by its iconic questions that help people “Match on What Matters,” creating love around the world for all communities.
  • Hinge — Hinge will give users who participate in their vaccination campaign a free “Rose,” which indicates to other users that they’re especially excited to get to know them. Hinge will encourage users to share their vaccination status on their profile starting June 1st. As the dating app “Designed To Be Deleted,” Hinge is excited to help get its community back out on dates and, ultimately, find a relationship.
  • Plenty of Fish — Members will be able to add an “I Got My Shot” badge to their profiles in early June. Those who participate will receive 20 Live! credits to use on the Plenty of Fish Live! streaming feature. In the spirit of Plenty of Fish’s mission to create low pressure dating experiences, this campaign will provide members with one less question to ask so they can start building meaningful connections.
  • BLK — BLK will add a new “Vaxified” profile badge for singles to show their support in ending the COVID-19 pandemic. When singles add the badge to their profile, they will also get a free “Boost” on the app to be one of the first profiles seen by their matches. The feature will be available starting June 1st. BLK is the #1 dating app made for Black singles with over 5 million downloads.
  • Chispa — Chispa will add a new “Vacunado” profile badge for Latinx singles to show their support for ending the pandemic. Singles who add the badge to their profile will get a free “Boost,” making them one of the first profiles to be seen by their matches. The feature will be available starting June 1st. Chispa is the #1 dating app made for Latino singles with over 4 million downloads (available in English and Spanish).

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”